Chemistry, Manufacturing, and Controls (CMC) | Live Virtual
The CMC Fundamentals Training Course is a specialized regulatory program
designed to provide comprehensive understanding of Chemistry, Manufacturing,
and Controls requirements for pharmaceutical and biotechnology products. This
curriculum addresses the critical CMC components required for regulatory
submissions (IND, NDA, BLA, MAA) and ongoing commercial manufacturing
compliance.
The program covers drug substance development, drug product manufacturing,
analytical method validation, specifications, stability programs, and
regulatory submission strategies. Participants shall acquire the competency
to develop CMC sections of regulatory dossiers, manage post-approval changes,
and maintain compliance throughout the product lifecycle.
REGULATORY FRAMEWORK AND COMPLIANCE
This course is developed in strict accordance with the following regulatory
standards and guidelines:
- FDA 21 CFR Part 210/211 (Current Good Manufacturing Practice)
- FDA 21 CFR Part 314 (NDA/ANDA Requirements)
- FDA 21 CFR Part 601 (BLA Requirements)
- ICH Q8 (Pharmaceutical Development)
- ICH Q9 (Quality Risk Management)
- ICH Q10 (Pharmaceutical Quality System)
- ICH Q11 (Drug Substance Development)
- ICH Q12 (Lifecycle Management)
- ICH Q13 (Continuous Manufacturing)
- ICH Q14 (Analytical Procedure Development)
LEARNING METHODOLOGY
The program utilizes a competency-based learning approach:
Expert Lectures: Regulatory and industry practitioners
Case Studies: Real CMC submissions and regulatory correspondence
Practical Workshops: Hands-on document preparation exercises
Group Discussions: Peer learning on CMC challenges
Assessment: Written examination to validate knowledge acquisition
TARGET PARTICIPANT PROFILE
This program is designed for professionals involved in CMC activities:
- CMC Regulatory Affairs Specialists
- Pharmaceutical Development Scientists
- Manufacturing and Process Engineers
- Quality Assurance and Control Personnel
- Analytical Development Scientists
- Technology Transfer Professionals
- Regulatory Submission Coordinators
- CMC Consultants and Contractors
CERTIFICATION AND COMPETENCY VALIDATION
Upon successful completion of the program, participants shall be awarded:
- Certificate of Attendance
- Requirement: Minimum 80% attendance (7 of 8 modules)
- Content: Participant name, course title, dates, contact hours
- Certificate of Completion
- Requirement: Minimum 80% attendance AND Final Assessment score >= 70%
- Content: Official seal, unique verification number, instructor signatures
- Validity: Recognized for Continuing Education Units (CEUs) where applicable
COURSE MATERIALS AND RESOURCES
All registered participants shall receive the following proprietary materials:
- Comprehensive CMC Course Manual (400+ pages, Printed and Digital)
- Presentation Slides (PDF Format - All 8 Modules)
- CMC Regulatory Reference Guide (FDA/EMA/ICH Guidelines)
- eCTD Module 3 Template and Examples
- CMC Protocol Templates (Validation, Stability, Transfer)
- Case Study Workbook (15+ Real CMC Scenarios)
- Assessment Workbook and Examination Materials
- USB Drive containing all digital resources
- Professional Certificate Holder
QUALITY ASSURANCE STATEMENT
Molgenium Training Department maintains a Quality Management System for all
educational programs. Course content is reviewed annually to ensure alignment
with current regulatory updates including ICH guideline revisions. Instructor
competency is verified through industry experience and regulatory background.
Participant feedback is collected and analyzed for continuous improvement.
REGISTRATION AND ADMINISTRATIVE INFORMATION
- Contact Email: training@molgenium.com
- Website: www.molgenium.com/training
- Organization: Molgenium (Dr. Mohamad)
- Payment Methods: Bank Transfer, Credit Card, Organizational Purchase Order
- Cancellation Policy: Full refund available up to 7 days prior to course start
- Substitution Policy: Participant substitution allowed up to 24 hours prior
EXPECTED COMPETENCY OUTCOMES
Following program completion, the participant shall demonstrate the ability to:
- Develop CMC sections for regulatory submissions (IND, NDA, BLA, MAA)
- Design drug substance and drug product development strategies
- Establish specifications and analytical methods per ICH guidelines
- Implement impurity control strategies per ICH Q3 and M7
- Design and manage stability programs per ICH Q1
- Execute process validation per FDA 3-stage framework
- Manage post-approval changes through appropriate regulatory pathways
- Prepare for and respond to CMC-focused regulatory inspections
